All News #Library
Biotech
Lassen reels in $85M Series B for PhII testing in thyroid eye disease
19 Dec 2023 //
ENDPTS
Lassen Presents Data on LASN01 for Treatment of Idiopathic Pulmonary Fibrosis
11 Sep 2023 //
BUSINESSWIRE
Lassen Presents Phase I Data on LASN01, an IL-11 Receptor-Blocking Antibody
24 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support